March 2025 Volume 17 Issue 3
Providing Current Information on

Health Insurance Industry Issues and Legislation

HHC Group March Newsletter 2025
Maximizing Savings on ESRD Dialysis Claims
A healthcare plan achieved total net savings of $750,524.79 (90.1% reduction) on an ESRD dialysis claim for a 56-year-old male patient by leveraging H.H.C. Group's innovative Reference-Based Pricing strategy. Read more to see how our transparent, predictable cost-containment solutions protect payor budgets and ensure fair reimbursements while preventing balance billing.
H.H.C. Group Releases 2024 Client Survey Results, Projects Key Healthcare Cost Trends for 2025
H.H.C. Group proudly announces the results of its annual client satisfaction survey. The results highlight H.H.C.'s continued success as a trusted partner for payors navigating in- and out-of-network medical claims and workers' compensation bills, especially high-cost line-item charges.
H.H.C. Group Achieves ISO Certification, Highlighting Commitment to Excellence in Healthcare Cost Containment
H.H.C. Group proudly announces achievement of the globally recognized ISO 9001:2015 certification with the expert guidance of ISOP Solutions. This certification validates H.H.C. Group's steadfast commitment to operational precision, compliance and delivering exceptional value to its clients.
H.H.C. Group Highlights Flat-Fee Approach to Dialysis Claim Review, Unveils Cost-Saving Case Study for March Kidney Month
H.H.C. Group proudly announces a groundbreaking case study that underscores the value of its innovative flat-fee approach to dialysis claim review. The study demonstrates how HHC's reference-based pricing (RBP) model enabled a healthcare plan to achieve an impressive 90.1% savings on a high-cost End-Stage Renal Disease (ESRD) dialysis claim—delivering over $750K in net savings.
3 proactive strategies for reducing the risk of catastrophic health care claims
Nearly 80% of employers view catastrophic healthcare claims—those exceeding $500,000 and sometimes reaching up to $4 million—as a major threat to their benefit plans. Brokers are advised to take proactive strategies to help employers mitigate this risk: implementing hyper-personalized wellness programs, scheduling timely interventions during peak business cycles and leveraging real-time benefits technology to drive cost savings and enhance long-term employee well-being.
Specialty drugs and cancer surgery claims will push up stop-loss renewal prices, says Cigna CFO
Cigna's CFO warns that rising costs from expensive specialty drugs like Keytruda and increased inpatient surgeries for critical conditions are set to drive stop-loss renewal prices higher in 2025. Last quarter, these cost pressures pushed claims-to-premium ratios 4 to 7 percentage points above expectations, forcing adjustments that will affect employer renewals. Cigna plans to counter these challenges through balanced pricing, affordability initiatives and improved operational efficiencies.
Health insurers denied 20% of claims in 2023, report shows
According to a recent KFF analysis reported by Axios, nearly 20% of claims submitted to Affordable Care Act marketplace plans were denied in 2023, with some insurers rejecting up to 33% of claims. This high denial rate—especially for out-of-network services—creates significant challenges for consumers trying to manage their medical expenses.